nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—EPHX2—Sorafenib—kidney cancer	0.458	0.746	CbGbCtD
Fulvestrant—CYP3A4—Everolimus—kidney cancer	0.0456	0.0742	CbGbCtD
Fulvestrant—CYP3A4—Temsirolimus—kidney cancer	0.0308	0.0501	CbGbCtD
Fulvestrant—CYP3A4—Pazopanib—kidney cancer	0.0162	0.0263	CbGbCtD
Fulvestrant—CYP3A4—Erlotinib—kidney cancer	0.0116	0.0188	CbGbCtD
Fulvestrant—CYP3A4—Paclitaxel—kidney cancer	0.0106	0.0172	CbGbCtD
Fulvestrant—CYP3A4—Sorafenib—kidney cancer	0.00939	0.0153	CbGbCtD
Fulvestrant—CYP3A4—Vinblastine—kidney cancer	0.00927	0.0151	CbGbCtD
Fulvestrant—CYP3A4—Vincristine—kidney cancer	0.00912	0.0148	CbGbCtD
Fulvestrant—CYP3A4—Sunitinib—kidney cancer	0.00761	0.0124	CbGbCtD
Fulvestrant—CYP3A4—Doxorubicin—kidney cancer	0.0057	0.00927	CbGbCtD
Fulvestrant—NR1H4—nephron tubule—kidney cancer	0.00484	0.0858	CbGeAlD
Fulvestrant—NR1H4—renal system—kidney cancer	0.0044	0.078	CbGeAlD
Fulvestrant—NR1H4—kidney—kidney cancer	0.00426	0.0754	CbGeAlD
Fulvestrant—EPHX2—nephron tubule—kidney cancer	0.00423	0.075	CbGeAlD
Fulvestrant—NR1H4—cortex of kidney—kidney cancer	0.00414	0.0734	CbGeAlD
Fulvestrant—ESRRA—nephron tubule—kidney cancer	0.00371	0.0657	CbGeAlD
Fulvestrant—EPHX2—cortex of kidney—kidney cancer	0.00362	0.0642	CbGeAlD
Fulvestrant—ESRRA—renal system—kidney cancer	0.00337	0.0597	CbGeAlD
Fulvestrant—ESRRA—kidney—kidney cancer	0.00326	0.0577	CbGeAlD
Fulvestrant—ESRRA—cortex of kidney—kidney cancer	0.00317	0.0562	CbGeAlD
Fulvestrant—CYP3A4—urine—kidney cancer	0.00316	0.056	CbGeAlD
Fulvestrant—ESRRA—cardiac atrium—kidney cancer	0.00302	0.0535	CbGeAlD
Fulvestrant—ESR2—renal system—kidney cancer	0.00202	0.0358	CbGeAlD
Fulvestrant—ESR2—kidney—kidney cancer	0.00196	0.0346	CbGeAlD
Fulvestrant—ESR2—gonad—kidney cancer	0.00181	0.0321	CbGeAlD
Fulvestrant—ESR1—renal system—kidney cancer	0.00139	0.0245	CbGeAlD
Fulvestrant—ESR1—kidney—kidney cancer	0.00134	0.0237	CbGeAlD
Fulvestrant—ESR1—gonad—kidney cancer	0.00124	0.022	CbGeAlD
Fulvestrant—CYP3A4—renal system—kidney cancer	0.000773	0.0137	CbGeAlD
Fulvestrant—CYP3A4—kidney—kidney cancer	0.000747	0.0132	CbGeAlD
Fulvestrant—Decreased appetite—Dactinomycin—kidney cancer	0.000216	0.00097	CcSEcCtD
Fulvestrant—Diarrhoea—Vinblastine—kidney cancer	0.000216	0.000969	CcSEcCtD
Fulvestrant—Abdominal pain—Sorafenib—kidney cancer	0.000215	0.000968	CcSEcCtD
Fulvestrant—Body temperature increased—Sorafenib—kidney cancer	0.000215	0.000968	CcSEcCtD
Fulvestrant—Diarrhoea—Everolimus—kidney cancer	0.000215	0.000965	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Sunitinib—kidney cancer	0.000214	0.000964	CcSEcCtD
Fulvestrant—Hyperhidrosis—Vincristine—kidney cancer	0.000214	0.000964	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Capecitabine—kidney cancer	0.000214	0.000963	CcSEcCtD
Fulvestrant—Pruritus—Erlotinib—kidney cancer	0.000214	0.000963	CcSEcCtD
Fulvestrant—Fatigue—Dactinomycin—kidney cancer	0.000214	0.000962	CcSEcCtD
Fulvestrant—Pain—Dactinomycin—kidney cancer	0.000212	0.000954	CcSEcCtD
Fulvestrant—Anorexia—Vincristine—kidney cancer	0.000211	0.00095	CcSEcCtD
Fulvestrant—Hepatic failure—Doxorubicin—kidney cancer	0.000211	0.000948	CcSEcCtD
Fulvestrant—Infection—Gemcitabine—kidney cancer	0.000209	0.000939	CcSEcCtD
Fulvestrant—Back pain—Paclitaxel—kidney cancer	0.000209	0.000938	CcSEcCtD
Fulvestrant—Dizziness—Vinblastine—kidney cancer	0.000208	0.000937	CcSEcCtD
Fulvestrant—Dizziness—Everolimus—kidney cancer	0.000208	0.000933	CcSEcCtD
Fulvestrant—Body temperature increased—Sunitinib—kidney cancer	0.000207	0.000932	CcSEcCtD
Fulvestrant—Abdominal pain—Sunitinib—kidney cancer	0.000207	0.000932	CcSEcCtD
Fulvestrant—Diarrhoea—Erlotinib—kidney cancer	0.000207	0.000931	CcSEcCtD
Fulvestrant—Nervous system disorder—Gemcitabine—kidney cancer	0.000206	0.000927	CcSEcCtD
Fulvestrant—Haemoglobin—Capecitabine—kidney cancer	0.000205	0.000919	CcSEcCtD
Fulvestrant—Skin disorder—Gemcitabine—kidney cancer	0.000204	0.000918	CcSEcCtD
Fulvestrant—Haemorrhage—Capecitabine—kidney cancer	0.000204	0.000914	CcSEcCtD
Fulvestrant—Hepatitis—Capecitabine—kidney cancer	0.000204	0.000914	CcSEcCtD
Fulvestrant—Hyperhidrosis—Gemcitabine—kidney cancer	0.000203	0.000914	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000203	0.000912	CcSEcCtD
Fulvestrant—Hot flush—Doxorubicin—kidney cancer	0.000203	0.000911	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000202	0.000908	CcSEcCtD
Fulvestrant—Pharyngitis—Capecitabine—kidney cancer	0.000202	0.000908	CcSEcCtD
Fulvestrant—Menopausal symptoms—Doxorubicin—kidney cancer	0.000201	0.000903	CcSEcCtD
Fulvestrant—Hypersensitivity—Sorafenib—kidney cancer	0.000201	0.000902	CcSEcCtD
Fulvestrant—Insomnia—Vincristine—kidney cancer	0.000201	0.000902	CcSEcCtD
Fulvestrant—Anorexia—Gemcitabine—kidney cancer	0.000201	0.000901	CcSEcCtD
Fulvestrant—Oedema peripheral—Capecitabine—kidney cancer	0.0002	0.000901	CcSEcCtD
Fulvestrant—Vomiting—Vinblastine—kidney cancer	0.0002	0.000901	CcSEcCtD
Fulvestrant—Dizziness—Erlotinib—kidney cancer	0.0002	0.0009	CcSEcCtD
Fulvestrant—Connective tissue disorder—Capecitabine—kidney cancer	0.0002	0.000899	CcSEcCtD
Fulvestrant—Vomiting—Everolimus—kidney cancer	0.0002	0.000897	CcSEcCtD
Fulvestrant—Anaemia—Paclitaxel—kidney cancer	0.0002	0.000897	CcSEcCtD
Fulvestrant—Paraesthesia—Vincristine—kidney cancer	0.000199	0.000895	CcSEcCtD
Fulvestrant—Rash—Everolimus—kidney cancer	0.000198	0.00089	CcSEcCtD
Fulvestrant—Dermatitis—Everolimus—kidney cancer	0.000198	0.000889	CcSEcCtD
Fulvestrant—Headache—Vinblastine—kidney cancer	0.000197	0.000887	CcSEcCtD
Fulvestrant—Angioedema—Paclitaxel—kidney cancer	0.000197	0.000886	CcSEcCtD
Fulvestrant—Headache—Everolimus—kidney cancer	0.000197	0.000884	CcSEcCtD
Fulvestrant—Abdominal pain—Dactinomycin—kidney cancer	0.000196	0.000882	CcSEcCtD
Fulvestrant—Body temperature increased—Dactinomycin—kidney cancer	0.000196	0.000882	CcSEcCtD
Fulvestrant—Asthenia—Sorafenib—kidney cancer	0.000196	0.000879	CcSEcCtD
Fulvestrant—Vertigo—Paclitaxel—kidney cancer	0.000194	0.000872	CcSEcCtD
Fulvestrant—Leukopenia—Paclitaxel—kidney cancer	0.000193	0.000868	CcSEcCtD
Fulvestrant—Hypersensitivity—Sunitinib—kidney cancer	0.000193	0.000868	CcSEcCtD
Fulvestrant—Decreased appetite—Vincristine—kidney cancer	0.000193	0.000866	CcSEcCtD
Fulvestrant—Pruritus—Sorafenib—kidney cancer	0.000193	0.000866	CcSEcCtD
Fulvestrant—Vomiting—Erlotinib—kidney cancer	0.000193	0.000866	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000192	0.000862	CcSEcCtD
Fulvestrant—Estradiol—CYP1A1—kidney cancer	0.000192	0.653	CrCbGaD
Fulvestrant—Gastrointestinal disorder—Vincristine—kidney cancer	0.000192	0.000861	CcSEcCtD
Fulvestrant—Fatigue—Vincristine—kidney cancer	0.000191	0.000859	CcSEcCtD
Fulvestrant—Rash—Erlotinib—kidney cancer	0.000191	0.000858	CcSEcCtD
Fulvestrant—Dermatitis—Erlotinib—kidney cancer	0.000191	0.000858	CcSEcCtD
Fulvestrant—Insomnia—Gemcitabine—kidney cancer	0.00019	0.000855	CcSEcCtD
Fulvestrant—Headache—Erlotinib—kidney cancer	0.00019	0.000853	CcSEcCtD
Fulvestrant—Constipation—Vincristine—kidney cancer	0.00019	0.000852	CcSEcCtD
Fulvestrant—Pain—Vincristine—kidney cancer	0.00019	0.000852	CcSEcCtD
Fulvestrant—Pain in extremity—Doxorubicin—kidney cancer	0.00019	0.000852	CcSEcCtD
Fulvestrant—Paraesthesia—Gemcitabine—kidney cancer	0.000189	0.000849	CcSEcCtD
Fulvestrant—Cough—Paclitaxel—kidney cancer	0.000188	0.000846	CcSEcCtD
Fulvestrant—Asthenia—Sunitinib—kidney cancer	0.000188	0.000846	CcSEcCtD
Fulvestrant—Dyspnoea—Gemcitabine—kidney cancer	0.000188	0.000843	CcSEcCtD
Fulvestrant—Nausea—Vinblastine—kidney cancer	0.000187	0.000841	CcSEcCtD
Fulvestrant—Nausea—Everolimus—kidney cancer	0.000186	0.000838	CcSEcCtD
Fulvestrant—Diarrhoea—Sorafenib—kidney cancer	0.000186	0.000838	CcSEcCtD
Fulvestrant—Pruritus—Sunitinib—kidney cancer	0.000186	0.000834	CcSEcCtD
Fulvestrant—Angiopathy—Capecitabine—kidney cancer	0.000185	0.00083	CcSEcCtD
Fulvestrant—Immune system disorder—Capecitabine—kidney cancer	0.000184	0.000826	CcSEcCtD
Fulvestrant—Myalgia—Paclitaxel—kidney cancer	0.000184	0.000826	CcSEcCtD
Fulvestrant—Chest pain—Paclitaxel—kidney cancer	0.000184	0.000826	CcSEcCtD
Fulvestrant—Arthralgia—Paclitaxel—kidney cancer	0.000184	0.000826	CcSEcCtD
Fulvestrant—Anxiety—Paclitaxel—kidney cancer	0.000183	0.000823	CcSEcCtD
Fulvestrant—Decreased appetite—Gemcitabine—kidney cancer	0.000183	0.000822	CcSEcCtD
Fulvestrant—Hypersensitivity—Dactinomycin—kidney cancer	0.000183	0.000822	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000183	0.00082	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000182	0.000816	CcSEcCtD
Fulvestrant—Fatigue—Gemcitabine—kidney cancer	0.000181	0.000815	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Vincristine—kidney cancer	0.000181	0.000815	CcSEcCtD
Fulvestrant—Dizziness—Sorafenib—kidney cancer	0.00018	0.00081	CcSEcCtD
Fulvestrant—Pain—Gemcitabine—kidney cancer	0.00018	0.000809	CcSEcCtD
Fulvestrant—Constipation—Gemcitabine—kidney cancer	0.00018	0.000809	CcSEcCtD
Fulvestrant—Nausea—Erlotinib—kidney cancer	0.00018	0.000809	CcSEcCtD
Fulvestrant—Diarrhoea—Sunitinib—kidney cancer	0.000179	0.000806	CcSEcCtD
Fulvestrant—Asthenia—Dactinomycin—kidney cancer	0.000178	0.0008	CcSEcCtD
Fulvestrant—Malnutrition—Capecitabine—kidney cancer	0.000177	0.000796	CcSEcCtD
Fulvestrant—Abdominal pain—Vincristine—kidney cancer	0.000175	0.000788	CcSEcCtD
Fulvestrant—Body temperature increased—Vincristine—kidney cancer	0.000175	0.000788	CcSEcCtD
Fulvestrant—Infection—Paclitaxel—kidney cancer	0.000175	0.000787	CcSEcCtD
Fulvestrant—Dizziness—Sunitinib—kidney cancer	0.000173	0.000779	CcSEcCtD
Fulvestrant—Vomiting—Sorafenib—kidney cancer	0.000173	0.000779	CcSEcCtD
Fulvestrant—Nervous system disorder—Paclitaxel—kidney cancer	0.000173	0.000776	CcSEcCtD
Fulvestrant—Rash—Sorafenib—kidney cancer	0.000172	0.000772	CcSEcCtD
Fulvestrant—Dermatitis—Sorafenib—kidney cancer	0.000172	0.000772	CcSEcCtD
Fulvestrant—Back pain—Capecitabine—kidney cancer	0.000171	0.00077	CcSEcCtD
Fulvestrant—Breast disorder—Doxorubicin—kidney cancer	0.000171	0.00077	CcSEcCtD
Fulvestrant—Skin disorder—Paclitaxel—kidney cancer	0.000171	0.000769	CcSEcCtD
Fulvestrant—Headache—Sorafenib—kidney cancer	0.000171	0.000767	CcSEcCtD
Fulvestrant—Hyperhidrosis—Paclitaxel—kidney cancer	0.00017	0.000765	CcSEcCtD
Fulvestrant—Diarrhoea—Dactinomycin—kidney cancer	0.00017	0.000763	CcSEcCtD
Fulvestrant—Anorexia—Paclitaxel—kidney cancer	0.000168	0.000755	CcSEcCtD
Fulvestrant—Vomiting—Sunitinib—kidney cancer	0.000167	0.000749	CcSEcCtD
Fulvestrant—Body temperature increased—Gemcitabine—kidney cancer	0.000166	0.000748	CcSEcCtD
Fulvestrant—Rash—Sunitinib—kidney cancer	0.000165	0.000743	CcSEcCtD
Fulvestrant—Dermatitis—Sunitinib—kidney cancer	0.000165	0.000742	CcSEcCtD
Fulvestrant—Headache—Sunitinib—kidney cancer	0.000164	0.000738	CcSEcCtD
Fulvestrant—Influenza—Doxorubicin—kidney cancer	0.000164	0.000736	CcSEcCtD
Fulvestrant—Anaemia—Capecitabine—kidney cancer	0.000164	0.000736	CcSEcCtD
Fulvestrant—Hypersensitivity—Vincristine—kidney cancer	0.000163	0.000734	CcSEcCtD
Fulvestrant—Nausea—Sorafenib—kidney cancer	0.000162	0.000727	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000161	0.000721	CcSEcCtD
Fulvestrant—Insomnia—Paclitaxel—kidney cancer	0.000159	0.000716	CcSEcCtD
Fulvestrant—Vertigo—Capecitabine—kidney cancer	0.000159	0.000715	CcSEcCtD
Fulvestrant—Asthenia—Vincristine—kidney cancer	0.000159	0.000715	CcSEcCtD
Fulvestrant—Leukopenia—Capecitabine—kidney cancer	0.000159	0.000713	CcSEcCtD
Fulvestrant—Paraesthesia—Paclitaxel—kidney cancer	0.000158	0.000711	CcSEcCtD
Fulvestrant—Vomiting—Dactinomycin—kidney cancer	0.000158	0.000709	CcSEcCtD
Fulvestrant—Dyspnoea—Paclitaxel—kidney cancer	0.000157	0.000706	CcSEcCtD
Fulvestrant—Rash—Dactinomycin—kidney cancer	0.000157	0.000703	CcSEcCtD
Fulvestrant—Nausea—Sunitinib—kidney cancer	0.000156	0.0007	CcSEcCtD
Fulvestrant—Dyspepsia—Paclitaxel—kidney cancer	0.000155	0.000697	CcSEcCtD
Fulvestrant—Cough—Capecitabine—kidney cancer	0.000155	0.000695	CcSEcCtD
Fulvestrant—Decreased appetite—Paclitaxel—kidney cancer	0.000153	0.000688	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000152	0.000684	CcSEcCtD
Fulvestrant—Fatigue—Paclitaxel—kidney cancer	0.000152	0.000683	CcSEcCtD
Fulvestrant—Diarrhoea—Vincristine—kidney cancer	0.000152	0.000682	CcSEcCtD
Fulvestrant—Asthenia—Gemcitabine—kidney cancer	0.000151	0.000678	CcSEcCtD
Fulvestrant—Myalgia—Capecitabine—kidney cancer	0.000151	0.000678	CcSEcCtD
Fulvestrant—Chest pain—Capecitabine—kidney cancer	0.000151	0.000678	CcSEcCtD
Fulvestrant—Arthralgia—Capecitabine—kidney cancer	0.000151	0.000678	CcSEcCtD
Fulvestrant—Pain—Paclitaxel—kidney cancer	0.000151	0.000677	CcSEcCtD
Fulvestrant—Constipation—Paclitaxel—kidney cancer	0.000151	0.000677	CcSEcCtD
Fulvestrant—Anxiety—Capecitabine—kidney cancer	0.00015	0.000675	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00015	0.000673	CcSEcCtD
Fulvestrant—Pruritus—Gemcitabine—kidney cancer	0.000149	0.000669	CcSEcCtD
Fulvestrant—Nausea—Dactinomycin—kidney cancer	0.000147	0.000663	CcSEcCtD
Fulvestrant—Dizziness—Vincristine—kidney cancer	0.000147	0.000659	CcSEcCtD
Fulvestrant—Infestation NOS—Doxorubicin—kidney cancer	0.000146	0.000657	CcSEcCtD
Fulvestrant—Infestation—Doxorubicin—kidney cancer	0.000146	0.000657	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000144	0.000647	CcSEcCtD
Fulvestrant—Diarrhoea—Gemcitabine—kidney cancer	0.000144	0.000647	CcSEcCtD
Fulvestrant—Infection—Capecitabine—kidney cancer	0.000144	0.000645	CcSEcCtD
Fulvestrant—Urinary tract infection—Doxorubicin—kidney cancer	0.000142	0.000638	CcSEcCtD
Fulvestrant—Nervous system disorder—Capecitabine—kidney cancer	0.000142	0.000637	CcSEcCtD
Fulvestrant—Vomiting—Vincristine—kidney cancer	0.000141	0.000634	CcSEcCtD
Fulvestrant—Skin disorder—Capecitabine—kidney cancer	0.00014	0.000631	CcSEcCtD
Fulvestrant—Sweating—Doxorubicin—kidney cancer	0.00014	0.00063	CcSEcCtD
Fulvestrant—Urticaria—Paclitaxel—kidney cancer	0.00014	0.000629	CcSEcCtD
Fulvestrant—Rash—Vincristine—kidney cancer	0.00014	0.000628	CcSEcCtD
Fulvestrant—Hyperhidrosis—Capecitabine—kidney cancer	0.00014	0.000628	CcSEcCtD
Fulvestrant—Dermatitis—Vincristine—kidney cancer	0.00014	0.000628	CcSEcCtD
Fulvestrant—Abdominal pain—Paclitaxel—kidney cancer	0.000139	0.000626	CcSEcCtD
Fulvestrant—Body temperature increased—Paclitaxel—kidney cancer	0.000139	0.000626	CcSEcCtD
Fulvestrant—Headache—Vincristine—kidney cancer	0.000139	0.000624	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000138	0.000621	CcSEcCtD
Fulvestrant—Anorexia—Capecitabine—kidney cancer	0.000138	0.000619	CcSEcCtD
Fulvestrant—Vomiting—Gemcitabine—kidney cancer	0.000134	0.000601	CcSEcCtD
Fulvestrant—Rash—Gemcitabine—kidney cancer	0.000133	0.000596	CcSEcCtD
Fulvestrant—Dermatitis—Gemcitabine—kidney cancer	0.000133	0.000596	CcSEcCtD
Fulvestrant—Haemoglobin—Doxorubicin—kidney cancer	0.000132	0.000592	CcSEcCtD
Fulvestrant—Headache—Gemcitabine—kidney cancer	0.000132	0.000592	CcSEcCtD
Fulvestrant—Nausea—Vincristine—kidney cancer	0.000132	0.000592	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000132	0.000592	CcSEcCtD
Fulvestrant—Haemorrhage—Doxorubicin—kidney cancer	0.000131	0.000589	CcSEcCtD
Fulvestrant—Hepatitis—Doxorubicin—kidney cancer	0.000131	0.000589	CcSEcCtD
Fulvestrant—Insomnia—Capecitabine—kidney cancer	0.000131	0.000588	CcSEcCtD
Fulvestrant—Pharyngitis—Doxorubicin—kidney cancer	0.00013	0.000585	CcSEcCtD
Fulvestrant—Paraesthesia—Capecitabine—kidney cancer	0.00013	0.000583	CcSEcCtD
Fulvestrant—Hypersensitivity—Paclitaxel—kidney cancer	0.00013	0.000583	CcSEcCtD
Fulvestrant—Oedema peripheral—Doxorubicin—kidney cancer	0.000129	0.000581	CcSEcCtD
Fulvestrant—Connective tissue disorder—Doxorubicin—kidney cancer	0.000129	0.000579	CcSEcCtD
Fulvestrant—Dyspnoea—Capecitabine—kidney cancer	0.000129	0.000579	CcSEcCtD
Fulvestrant—Dyspepsia—Capecitabine—kidney cancer	0.000127	0.000572	CcSEcCtD
Fulvestrant—Asthenia—Paclitaxel—kidney cancer	0.000126	0.000568	CcSEcCtD
Fulvestrant—Decreased appetite—Capecitabine—kidney cancer	0.000126	0.000565	CcSEcCtD
Fulvestrant—Nausea—Gemcitabine—kidney cancer	0.000125	0.000562	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000125	0.000561	CcSEcCtD
Fulvestrant—Fatigue—Capecitabine—kidney cancer	0.000125	0.00056	CcSEcCtD
Fulvestrant—Pruritus—Paclitaxel—kidney cancer	0.000125	0.00056	CcSEcCtD
Fulvestrant—Pain—Capecitabine—kidney cancer	0.000124	0.000556	CcSEcCtD
Fulvestrant—Constipation—Capecitabine—kidney cancer	0.000124	0.000556	CcSEcCtD
Fulvestrant—Diarrhoea—Paclitaxel—kidney cancer	0.000121	0.000542	CcSEcCtD
Fulvestrant—Angiopathy—Doxorubicin—kidney cancer	0.000119	0.000535	CcSEcCtD
Fulvestrant—Immune system disorder—Doxorubicin—kidney cancer	0.000118	0.000532	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Capecitabine—kidney cancer	0.000118	0.000531	CcSEcCtD
Fulvestrant—Dizziness—Paclitaxel—kidney cancer	0.000117	0.000524	CcSEcCtD
Fulvestrant—Urticaria—Capecitabine—kidney cancer	0.000115	0.000516	CcSEcCtD
Fulvestrant—Body temperature increased—Capecitabine—kidney cancer	0.000114	0.000514	CcSEcCtD
Fulvestrant—Abdominal pain—Capecitabine—kidney cancer	0.000114	0.000514	CcSEcCtD
Fulvestrant—Malnutrition—Doxorubicin—kidney cancer	0.000114	0.000513	CcSEcCtD
Fulvestrant—Vomiting—Paclitaxel—kidney cancer	0.000112	0.000503	CcSEcCtD
Fulvestrant—Rash—Paclitaxel—kidney cancer	0.000111	0.000499	CcSEcCtD
Fulvestrant—Dermatitis—Paclitaxel—kidney cancer	0.000111	0.000499	CcSEcCtD
Fulvestrant—Back pain—Doxorubicin—kidney cancer	0.00011	0.000496	CcSEcCtD
Fulvestrant—Headache—Paclitaxel—kidney cancer	0.00011	0.000496	CcSEcCtD
Fulvestrant—Hypersensitivity—Capecitabine—kidney cancer	0.000107	0.000479	CcSEcCtD
Fulvestrant—Anaemia—Doxorubicin—kidney cancer	0.000106	0.000474	CcSEcCtD
Fulvestrant—Nausea—Paclitaxel—kidney cancer	0.000105	0.00047	CcSEcCtD
Fulvestrant—Asthenia—Capecitabine—kidney cancer	0.000104	0.000466	CcSEcCtD
Fulvestrant—Vertigo—Doxorubicin—kidney cancer	0.000103	0.000461	CcSEcCtD
Fulvestrant—Pruritus—Capecitabine—kidney cancer	0.000102	0.00046	CcSEcCtD
Fulvestrant—Leukopenia—Doxorubicin—kidney cancer	0.000102	0.000459	CcSEcCtD
Fulvestrant—Estradiol—ABCB1—kidney cancer	0.000102	0.347	CrCbGaD
Fulvestrant—Cough—Doxorubicin—kidney cancer	9.96e-05	0.000448	CcSEcCtD
Fulvestrant—Diarrhoea—Capecitabine—kidney cancer	9.89e-05	0.000445	CcSEcCtD
Fulvestrant—Arthralgia—Doxorubicin—kidney cancer	9.72e-05	0.000437	CcSEcCtD
Fulvestrant—Chest pain—Doxorubicin—kidney cancer	9.72e-05	0.000437	CcSEcCtD
Fulvestrant—Myalgia—Doxorubicin—kidney cancer	9.72e-05	0.000437	CcSEcCtD
Fulvestrant—Anxiety—Doxorubicin—kidney cancer	9.69e-05	0.000435	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	9.65e-05	0.000434	CcSEcCtD
Fulvestrant—Dizziness—Capecitabine—kidney cancer	9.56e-05	0.00043	CcSEcCtD
Fulvestrant—Infection—Doxorubicin—kidney cancer	9.26e-05	0.000416	CcSEcCtD
Fulvestrant—Vomiting—Capecitabine—kidney cancer	9.19e-05	0.000413	CcSEcCtD
Fulvestrant—Nervous system disorder—Doxorubicin—kidney cancer	9.14e-05	0.000411	CcSEcCtD
Fulvestrant—Rash—Capecitabine—kidney cancer	9.12e-05	0.00041	CcSEcCtD
Fulvestrant—Dermatitis—Capecitabine—kidney cancer	9.11e-05	0.000409	CcSEcCtD
Fulvestrant—Headache—Capecitabine—kidney cancer	9.06e-05	0.000407	CcSEcCtD
Fulvestrant—Skin disorder—Doxorubicin—kidney cancer	9.05e-05	0.000407	CcSEcCtD
Fulvestrant—Hyperhidrosis—Doxorubicin—kidney cancer	9.01e-05	0.000405	CcSEcCtD
Fulvestrant—ESR1—Gene Expression—EIF5B—kidney cancer	8.91e-05	0.000839	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—BCHE—kidney cancer	8.91e-05	0.000839	CbGpPWpGaD
Fulvestrant—Anorexia—Doxorubicin—kidney cancer	8.88e-05	0.000399	CcSEcCtD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	8.82e-05	0.000831	CbGpPWpGaD
Fulvestrant—ESR1—Validated nuclear estrogen receptor alpha network—MYC—kidney cancer	8.8e-05	0.000829	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—SLC5A5—kidney cancer	8.8e-05	0.000829	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	8.76e-05	0.000825	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—JUNB—kidney cancer	8.67e-05	0.000817	CbGpPWpGaD
Fulvestrant—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	8.67e-05	0.000817	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—MAPK3—kidney cancer	8.62e-05	0.000812	CbGpPWpGaD
Fulvestrant—Nausea—Capecitabine—kidney cancer	8.59e-05	0.000386	CcSEcCtD
Fulvestrant—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	8.51e-05	0.000801	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—SLC2A1—kidney cancer	8.5e-05	0.0008	CbGpPWpGaD
Fulvestrant—Musculoskeletal discomfort—Doxorubicin—kidney cancer	8.49e-05	0.000382	CcSEcCtD
Fulvestrant—Insomnia—Doxorubicin—kidney cancer	8.43e-05	0.000379	CcSEcCtD
Fulvestrant—ESR1—Regulation of Telomerase—MYC—kidney cancer	8.39e-05	0.00079	CbGpPWpGaD
Fulvestrant—Paraesthesia—Doxorubicin—kidney cancer	8.37e-05	0.000376	CcSEcCtD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—ABCB1—kidney cancer	8.37e-05	0.000788	CbGpPWpGaD
Fulvestrant—Dyspnoea—Doxorubicin—kidney cancer	8.31e-05	0.000373	CcSEcCtD
Fulvestrant—NR1H4—Metabolism—CA9—kidney cancer	8.29e-05	0.000781	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.26e-05	0.000778	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.24e-05	0.000777	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—MAPK1—kidney cancer	8.2e-05	0.000773	CbGpPWpGaD
Fulvestrant—Dyspepsia—Doxorubicin—kidney cancer	8.2e-05	0.000369	CcSEcCtD
Fulvestrant—ESR1—AP-1 transcription factor network—MYC—kidney cancer	8.19e-05	0.000772	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GSTT1—kidney cancer	8.17e-05	0.00077	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ACHE—kidney cancer	8.17e-05	0.00077	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—RPL14—kidney cancer	8.11e-05	0.000764	CbGpPWpGaD
Fulvestrant—Decreased appetite—Doxorubicin—kidney cancer	8.1e-05	0.000364	CcSEcCtD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.1e-05	0.000763	CbGpPWpGaD
Fulvestrant—Gastrointestinal disorder—Doxorubicin—kidney cancer	8.05e-05	0.000362	CcSEcCtD
Fulvestrant—Fatigue—Doxorubicin—kidney cancer	8.04e-05	0.000361	CcSEcCtD
Fulvestrant—ESR1—Signaling by ERBB4—KIT—kidney cancer	8.01e-05	0.000754	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—MAPK3—kidney cancer	7.97e-05	0.000751	CbGpPWpGaD
Fulvestrant—Constipation—Doxorubicin—kidney cancer	7.97e-05	0.000358	CcSEcCtD
Fulvestrant—Pain—Doxorubicin—kidney cancer	7.97e-05	0.000358	CcSEcCtD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	7.91e-05	0.000745	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—SCARB1—kidney cancer	7.74e-05	0.000729	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTGS1—kidney cancer	7.66e-05	0.000721	CbGpPWpGaD
Fulvestrant—Gastrointestinal pain—Doxorubicin—kidney cancer	7.62e-05	0.000342	CcSEcCtD
Fulvestrant—NR1H4—Gene Expression—HSPB1—kidney cancer	7.59e-05	0.000715	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—EIF4EBP1—kidney cancer	7.59e-05	0.000715	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—MAPK1—kidney cancer	7.59e-05	0.000715	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—BRAF—kidney cancer	7.57e-05	0.000713	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PSMD7—kidney cancer	7.51e-05	0.000708	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	7.48e-05	0.000705	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—CDH1—kidney cancer	7.41e-05	0.000698	CbGpPWpGaD
Fulvestrant—Urticaria—Doxorubicin—kidney cancer	7.4e-05	0.000333	CcSEcCtD
Fulvestrant—Body temperature increased—Doxorubicin—kidney cancer	7.37e-05	0.000331	CcSEcCtD
Fulvestrant—Abdominal pain—Doxorubicin—kidney cancer	7.37e-05	0.000331	CcSEcCtD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	7.29e-05	0.000687	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	7.28e-05	0.000686	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.19e-05	0.000677	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	7.12e-05	0.000671	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—BCHE—kidney cancer	7.12e-05	0.000671	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GSTP1—kidney cancer	7.09e-05	0.000668	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—PSMD7—kidney cancer	7.06e-05	0.000665	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—CDKN2B—kidney cancer	7.06e-05	0.000665	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CRABP1—kidney cancer	7.05e-05	0.000664	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—SLC5A5—kidney cancer	7.03e-05	0.000663	CbGpPWpGaD
Fulvestrant—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	7.01e-05	0.00066	CbGpPWpGaD
Fulvestrant—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	6.92e-05	0.000652	CbGpPWpGaD
Fulvestrant—Hypersensitivity—Doxorubicin—kidney cancer	6.87e-05	0.000309	CcSEcCtD
Fulvestrant—ESR1—Signaling Pathways—OR4C13—kidney cancer	6.81e-05	0.000642	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—SLC2A1—kidney cancer	6.79e-05	0.00064	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—TP53—kidney cancer	6.73e-05	0.000634	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	6.73e-05	0.000634	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—ABCB1—kidney cancer	6.71e-05	0.000632	CbGpPWpGaD
Fulvestrant—Asthenia—Doxorubicin—kidney cancer	6.69e-05	0.0003	CcSEcCtD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	6.67e-05	0.000628	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—HSPB1—kidney cancer	6.61e-05	0.000623	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—EIF4EBP1—kidney cancer	6.61e-05	0.000623	CbGpPWpGaD
Fulvestrant—Pruritus—Doxorubicin—kidney cancer	6.59e-05	0.000296	CcSEcCtD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.59e-05	0.000621	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ITPR2—kidney cancer	6.55e-05	0.000617	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GSTM1—kidney cancer	6.51e-05	0.000613	CbGpPWpGaD
Fulvestrant—Diarrhoea—Doxorubicin—kidney cancer	6.38e-05	0.000287	CcSEcCtD
Fulvestrant—NR1H4—Gene Expression—JUNB—kidney cancer	6.34e-05	0.000597	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—RAF1—kidney cancer	6.29e-05	0.000592	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—ERBB2—kidney cancer	6.22e-05	0.000586	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	6.18e-05	0.000582	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CYP1A1—kidney cancer	6.17e-05	0.000582	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—MTOR—kidney cancer	6.17e-05	0.000581	CbGpPWpGaD
Fulvestrant—Dizziness—Doxorubicin—kidney cancer	6.16e-05	0.000277	CcSEcCtD
Fulvestrant—ESR2—Gene Expression—PSMD7—kidney cancer	6.15e-05	0.000579	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—MTOR—kidney cancer	6.14e-05	0.000578	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.04e-05	0.000569	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	5.98e-05	0.000563	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ACHE—kidney cancer	5.97e-05	0.000563	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GSTT1—kidney cancer	5.97e-05	0.000563	CbGpPWpGaD
Fulvestrant—Vomiting—Doxorubicin—kidney cancer	5.93e-05	0.000266	CcSEcCtD
Fulvestrant—Rash—Doxorubicin—kidney cancer	5.88e-05	0.000264	CcSEcCtD
Fulvestrant—Dermatitis—Doxorubicin—kidney cancer	5.87e-05	0.000264	CcSEcCtD
Fulvestrant—Headache—Doxorubicin—kidney cancer	5.84e-05	0.000262	CcSEcCtD
Fulvestrant—ESR1—Signaling Pathways—LATS1—kidney cancer	5.79e-05	0.000546	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—JUNB—kidney cancer	5.78e-05	0.000544	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—CDKN1B—kidney cancer	5.76e-05	0.000542	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.75e-05	0.000541	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—EEF2—kidney cancer	5.74e-05	0.000541	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	5.68e-05	0.000535	CbGpPWpGaD
Fulvestrant—ESRRA—Generic Transcription Pathway—MYC—kidney cancer	5.68e-05	0.000535	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GSTP1—kidney cancer	5.67e-05	0.000534	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—SCARB1—kidney cancer	5.65e-05	0.000533	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTGS1—kidney cancer	5.6e-05	0.000527	CbGpPWpGaD
Fulvestrant—Nausea—Doxorubicin—kidney cancer	5.54e-05	0.000249	CcSEcCtD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—CCND1—kidney cancer	5.52e-05	0.00052	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—JUNB—kidney cancer	5.52e-05	0.00052	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—JUN—kidney cancer	5.51e-05	0.000519	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—TET2—kidney cancer	5.5e-05	0.000518	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PSMD7—kidney cancer	5.49e-05	0.000517	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	5.47e-05	0.000515	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ABCB1—kidney cancer	5.36e-05	0.000505	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—PTEN—kidney cancer	5.33e-05	0.000502	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—PTEN—kidney cancer	5.3e-05	0.000499	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	5.24e-05	0.000493	CbGpPWpGaD
Fulvestrant—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	5.23e-05	0.000492	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GSTM1—kidney cancer	5.21e-05	0.00049	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—BCHE—kidney cancer	5.2e-05	0.00049	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	5.18e-05	0.000488	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—CDKN2B—kidney cancer	5.16e-05	0.000486	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—SLC5A5—kidney cancer	5.14e-05	0.000484	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.07e-05	0.000478	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	5.06e-05	0.000477	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—TCEB1—kidney cancer	5.03e-05	0.000474	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—TCEB2—kidney cancer	5.03e-05	0.000474	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTT1—kidney cancer	5e-05	0.000471	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—SLC2A1—kidney cancer	4.96e-05	0.000468	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CYP1A1—kidney cancer	4.94e-05	0.000465	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AMER1—kidney cancer	4.92e-05	0.000464	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.82e-05	0.000454	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	4.81e-05	0.000454	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	4.8e-05	0.000452	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—RAF1—kidney cancer	4.73e-05	0.000446	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—CDKN2B—kidney cancer	4.71e-05	0.000443	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—PTGS1—kidney cancer	4.68e-05	0.000441	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—POMC—kidney cancer	4.6e-05	0.000434	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	4.58e-05	0.000431	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	4.57e-05	0.00043	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	4.53e-05	0.000427	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—MAPK3—kidney cancer	4.53e-05	0.000427	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—CDKN2B—kidney cancer	4.49e-05	0.000423	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—MYC—kidney cancer	4.43e-05	0.000417	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	4.42e-05	0.000416	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	4.33e-05	0.000408	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—MAPK1—kidney cancer	4.31e-05	0.000406	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.24e-05	0.000399	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.2e-05	0.000396	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—MYC—kidney cancer	4.15e-05	0.000391	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GSTP1—kidney cancer	4.14e-05	0.00039	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GPC3—kidney cancer	4.13e-05	0.000389	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CER1—kidney cancer	4.13e-05	0.000389	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—KRAS—kidney cancer	4.09e-05	0.000386	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—RPL14—kidney cancer	4.09e-05	0.000385	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—KRAS—kidney cancer	4.07e-05	0.000384	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.05e-05	0.000382	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.99e-05	0.000376	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ABCB1—kidney cancer	3.92e-05	0.000369	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GSTM1—kidney cancer	3.8e-05	0.000358	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	3.77e-05	0.000356	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—PIK3CA—kidney cancer	3.74e-05	0.000352	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—POMC—kidney cancer	3.68e-05	0.000347	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PTGS2—kidney cancer	3.67e-05	0.000346	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	3.67e-05	0.000346	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—TP53—kidney cancer	3.64e-05	0.000343	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—MYC—kidney cancer	3.62e-05	0.000341	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CYP1A1—kidney cancer	3.61e-05	0.00034	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	3.59e-05	0.000338	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SFRP2—kidney cancer	3.51e-05	0.000331	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTP1—kidney cancer	3.47e-05	0.000326	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	3.42e-05	0.000322	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	3.39e-05	0.000319	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—EIF4EBP1—kidney cancer	3.33e-05	0.000314	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—HSPB1—kidney cancer	3.33e-05	0.000314	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PTEN—kidney cancer	3.2e-05	0.000302	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.18e-05	0.0003	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3.14e-05	0.000296	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	3.12e-05	0.000294	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PSMD7—kidney cancer	3.1e-05	0.000292	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	3.02e-05	0.000284	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	3.01e-05	0.000284	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.98e-05	0.00028	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.96e-05	0.000279	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTGS2—kidney cancer	2.94e-05	0.000276	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CASP2—kidney cancer	2.83e-05	0.000266	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AKAP13—kidney cancer	2.83e-05	0.000266	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—MAPK3—kidney cancer	2.81e-05	0.000265	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—JUNB—kidney cancer	2.78e-05	0.000262	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—MYC—kidney cancer	2.74e-05	0.000258	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—POMC—kidney cancer	2.69e-05	0.000253	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ACY1—kidney cancer	2.66e-05	0.00025	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GRB7—kidney cancer	2.59e-05	0.000244	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTEN—kidney cancer	2.56e-05	0.000241	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ITPR2—kidney cancer	2.41e-05	0.000227	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—CDKN2B—kidney cancer	2.27e-05	0.000213	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PIK3CA—kidney cancer	2.26e-05	0.000213	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PDHB—kidney cancer	2.26e-05	0.000213	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—POMC—kidney cancer	2.25e-05	0.000212	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CTNNA1—kidney cancer	2.18e-05	0.000205	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HSPB1—kidney cancer	2.17e-05	0.000204	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EIF4EBP1—kidney cancer	2.17e-05	0.000204	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTGS2—kidney cancer	2.14e-05	0.000202	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CCBL1—kidney cancer	2.12e-05	0.0002	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—MAPK3—kidney cancer	2.06e-05	0.000194	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ANXA1—kidney cancer	2.02e-05	0.00019	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PSMD7—kidney cancer	2.02e-05	0.00019	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TSC1—kidney cancer	2.02e-05	0.00019	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—MYC—kidney cancer	2e-05	0.000188	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FLT1—kidney cancer	1.95e-05	0.000184	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTEN—kidney cancer	1.87e-05	0.000176	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.84e-05	0.000173	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPAT—kidney cancer	1.84e-05	0.000173	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—MYC—kidney cancer	1.82e-05	0.000172	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PAK1—kidney cancer	1.81e-05	0.00017	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—JUNB—kidney cancer	1.81e-05	0.00017	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3CA—kidney cancer	1.81e-05	0.00017	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—MAPK3—kidney cancer	1.79e-05	0.000169	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—MYC—kidney cancer	1.74e-05	0.000164	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APRT—kidney cancer	1.71e-05	0.000161	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—FH—kidney cancer	1.71e-05	0.000161	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GPC3—kidney cancer	1.61e-05	0.000152	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CA2—kidney cancer	1.57e-05	0.000147	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALAD—kidney cancer	1.53e-05	0.000144	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.49e-05	0.00014	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IGF2—kidney cancer	1.48e-05	0.000139	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CDKN2B—kidney cancer	1.47e-05	0.000139	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.46e-05	0.000137	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IGF1R—kidney cancer	1.43e-05	0.000135	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PGK1—kidney cancer	1.39e-05	0.000131	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.39e-05	0.000131	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LDHB—kidney cancer	1.37e-05	0.000129	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CA—kidney cancer	1.32e-05	0.000124	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CA9—kidney cancer	1.19e-05	0.000112	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HIF1A—kidney cancer	1.18e-05	0.000111	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TSC2—kidney cancer	1.17e-05	0.000111	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KDR—kidney cancer	1.13e-05	0.000106	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APC—kidney cancer	1.04e-05	9.77e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KIT—kidney cancer	1.04e-05	9.77e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CRABP1—kidney cancer	1.01e-05	9.5e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—POMC—kidney cancer	9.87e-06	9.3e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—BRAF—kidney cancer	9.75e-06	9.18e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ITPR2—kidney cancer	9.38e-06	8.83e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—MAPK3—kidney cancer	9.03e-06	8.5e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—MYC—kidney cancer	8.78e-06	8.27e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTT1—kidney cancer	8.55e-06	8.05e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ACHE—kidney cancer	8.55e-06	8.05e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RAF1—kidney cancer	8.14e-06	7.67e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RELA—kidney cancer	8.11e-06	7.64e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SCARB1—kidney cancer	8.09e-06	7.62e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ERBB2—kidney cancer	8.05e-06	7.59e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTGS1—kidney cancer	8.01e-06	7.55e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MTOR—kidney cancer	7.95e-06	7.49e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PSMD7—kidney cancer	7.86e-06	7.4e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CDKN1B—kidney cancer	7.46e-06	7.03e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—BCHE—kidney cancer	7.45e-06	7.02e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC5A5—kidney cancer	7.36e-06	6.93e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL2—kidney cancer	7.3e-06	6.88e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCND1—kidney cancer	7.12e-06	6.7e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC2A1—kidney cancer	7.11e-06	6.69e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—JUN—kidney cancer	7.1e-06	6.69e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CTNNB1—kidney cancer	7.05e-06	6.64e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTEN—kidney cancer	6.87e-06	6.47e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VEGFA—kidney cancer	6.2e-06	5.84e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTP1—kidney cancer	5.93e-06	5.58e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MAPK3—kidney cancer	5.87e-06	5.53e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MYC—kidney cancer	5.71e-06	5.38e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ABCB1—kidney cancer	5.61e-06	5.28e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MAPK1—kidney cancer	5.58e-06	5.26e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTM1—kidney cancer	5.45e-06	5.13e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KRAS—kidney cancer	5.27e-06	4.97e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.16e-06	4.86e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CA—kidney cancer	4.85e-06	4.56e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TP53—kidney cancer	4.69e-06	4.42e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—POMC—kidney cancer	3.85e-06	3.63e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTGS2—kidney cancer	3.07e-06	2.89e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTEN—kidney cancer	2.68e-06	2.52e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.89e-06	1.78e-05	CbGpPWpGaD
